Satraplatin in the treatment of hormone-refractory prostate cancer

BJU Int. 2005 Nov;96(7):990-4. doi: 10.1111/j.1464-410X.2005.05799.x.
No abstract available

Publication types

  • Meta-Analysis

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / mortality
  • Adenocarcinoma / pathology
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Disease-Free Survival
  • Humans
  • Male
  • Middle Aged
  • Organoplatinum Compounds / administration & dosage*
  • Prednisolone / administration & dosage
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / pathology
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Organoplatinum Compounds
  • satraplatin
  • Prednisolone